Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Apr;4(2):55-9.

Ocular toxicity of systemic anticancer chemotherapy

Afekhide Ernest Omoti  1 , Caroline Edijana Omoti  2
Affiliations
Review

Ocular toxicity of systemic anticancer chemotherapy

Afekhide Ernest Omoti et al. Pharm Pract (Granada). 2006 Apr.

Abstract

The increased use of chemotherapeutic agents has resulted in longer cancer patient survival. Consequently the ophthalmologist is seeing more patients with adverse ocular side effects secondary to these antineoplastic agents. Ocular toxicity induced by cancer chemotherapy includes a broad spectrum of disorders, reflecting the unique anatomical, physiological and biochemical features of the eye. Understanding the ocular side effects will assist the ophthalmologist and oncologist to recognize them early and intervene before blindness occurs. Anticipation of various treatment-related toxicities may also provide the opportunity for pharmacists to develop intervention strategies that could minimize or eliminate an expected side effect. The ophthalmologist should examine patients on anticancer therapy at baseline and three monthly thereafter. The various ocular side effects of anticancer chemotherapeutic agents, tamoxifen, and interferon on the adnexia, anterior segment, posterior segment and neuro-ophthalmic structures were reviewed.

Keywords: Adverse drug effects; Anticancer drugs; Chemotherapy; Interferon; Nigeria; Tamoxifen.

PubMed Disclaimer

References

    1. Moorthy RS, Valluri S. Ocular toxicity associated with systemic drug therapy. Curr Opin Ophthalmol. 1999;10(6):438–46. - PubMed
    1. al-Tweigeri T, Nabholtz JM, Mackey JR. Ocular toxicity and cancer chemotherapy. A review. Cancer. 1996;78(7):1359–73. - PubMed
    1. Vizel M, Oster MW. Ocular side effects of cancer chemotherapy. Cancer. 1982;49(10):1999–2002. - PubMed
    1. Jean McCann. New drugs, better treatments lessen side effects of cancer care. Journal of the National Cancer Institute. 2000;92(6):449–51. - PubMed
    1. Fraunfelder FT, Meyer SM. Ocular toxicity of antineoplastic agents. Ophthalmology. 1983;90(1):1–3. - PubMed

LinkOut - more resources